Pipeline
Akretiv's current pipeline consists of independently managed animal health development programs. The public descriptions below are intentionally limited. Detailed target product profiles (TPPs), development plans and budgets may be made available to qualified parties under confidentiality when completed.
| Program | Therapeutic Area | Target opportunity | Status |
|---|---|---|---|
| SPV-Bactilys | Respiratory and immune health | Oral immune-support approach for respiratory health in horses and cats. | FDA/USDA jurisdictional committee response pending. Budgets for equine and feline proof-of-concept clinical studies pending. |
| SPV-BenzoVet | Neurology / seizure rescue | Intranasal product intended to provide rapid, practical seizure control for dogs, including at-home use. | Formulation work completed. Pre-INAD meeting pending. No funding needed at this stage. |
Additional scientific, regulatory and financial information may be shared with qualified investors or strategic partners under a confidentiality agreement. Public program status will be updated as material milestones are reached.